You just read:

Sprout Pharmaceuticals Appeals FDA Decision On New Drug Application For Flibanserin To Treat Hypoactive Sexual Desire Disorder In Premenopausal Women

News provided by

Sprout Pharmaceuticals

Dec 21, 2016, 02:00 ET